Abstract
Molecular imaging is a multimodality discipline for noninvasively visualizing biologic processes at the subcellular level. Clinical applications of radionuclide-based molecular imaging for breast cancer continue to evolve. Whole-body imaging, with scintimammography and PET, and newer dedicated breast imaging systems are reviewed. The potential clinical indications and the challenges of implementing these emerging technologies are presented.
- molecular imaging
- oncology
- breast
- PET
- PET/CT
- radiopharmaceuticals
- breast cancer
- breast-specific γ imaging
- positron-emission mammography
- positron-emission tomography
Footnotes
Published online ▪▪▪▪▪▪▪▪▪▪▪▪.
- © 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
In this issue
Jump to section
Related Articles
Cited By...
- SNMMI Procedure Standard/EANM Practice Guideline for Molecular Breast Imaging with Dedicated {gamma}-Cameras
- Breast Cancer: Evaluating Tumor Estrogen Receptor Status with Molecular Imaging to Increase Response to Therapy and Improve Patient Outcomes
- Classification of Abnormal Findings on Ring-type Dedicated Breast PET for the Detection of Breast Cancer
- Anti-3-18F-FACBC (18F-Fluciclovine) PET/CT of Breast Cancer: An Exploratory Study
- Molecular Imaging Approaches for Supplemental Screening in Women at Increased Breast Cancer Risk
- Advancements in Molecular Breast Imaging